In response to a report in the Journal of the American Medical Association, which found that adverse drug reactions may be one of the top 10 leading causes of death in hospital patients (see Pharmaceutical Representative, June 1998), Milwaukee-based Schwarz Pharma Inc. distributed a list of questions patients should ask physicians before taking prescription medicines.
In response to a report in the Journal of the American Medical Association, which found that adverse drug reactions may be one of the top 10 leading causes of death in hospital patients (see Pharmaceutical Representative, June 1998), Milwaukee-based Schwarz Pharma Inc. distributed a list of questions patients should ask physicians before taking prescription medicines.
The list, which is posted on the company's Web site, directs patients to their physicians and pharmacists for answers to their questions.
"With the availability of so many medical information sources, including direct-to-consumer advertising, it's critical for patients to seek an expert's opinion about any treatment or medication plan," said Joseph Bianchine, M.D., Schwarz Pharma's medical director.
According to Schwarz Pharma, patients should ask:
•Â For what specific condition or treatment are you prescribing this medication?
•Â Are there other treatment options available? Alternative drugs? Generics?
•Â How am I directed to take this medicine? When should I take this medicine? In what amount? Should I take it with or without food?
•Â How long will I remain on this medication - long-term for a chronic condition, or short-term for an acute condition?
•Â What are the potential side effects of this medicine?
•Â Under what circumstances should I discontinue use of this medication? For example, should I take the medication if I have high blood pressure, am pregnant or breast feed?
•Â If I am taking other medications, is there an increased risk for potential side effects or adverse reactions?
•Â After reading the information provided by the drug manufacturer and my pharmacist, do I have any additional questions?
Schwarz Pharma also encouraged patients to provide their physicians with lists of all prescription and over-the-counter medications they take, and alert their physicians and pharmacists of personal or family medical history that could impact tolerance or reaction to particular medications.
The company also recommended that patients comply with dosage and regimen instructions, educate themselves about potential side effects and adverse reactions and avoid borrowing or loaning prescribed medications to friends and family members. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.